BR0008472A -
Method for human in vitro fertilization, use of a hypothalamic hormone and / or a pituitary hormone or an agonist or antagonist of these or an active derivative of these and a pharmaceutical unit in the form of a dosage unit for use in IVF
- Google Patents
Method for human in vitro fertilization, use of a hypothalamic hormone and / or a pituitary hormone or an agonist or antagonist of these or an active derivative of these and a pharmaceutical unit in the form of a dosage unit for use in IVF
Info
Publication number
BR0008472A
BR0008472ABR0008472-7ABR0008472ABR0008472ABR 0008472 ABR0008472 ABR 0008472ABR 0008472 ABR0008472 ABR 0008472ABR 0008472 ABR0008472 ABR 0008472A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novo Nordisk AsfiledCriticalNovo Nordisk As
Priority claimed from PCT/DK2000/000073external-prioritypatent/WO2000050065A1/en
Publication of BR0008472ApublicationCriticalpatent/BR0008472A/en
Medicines That Contain Protein Lipid Enzymes And Other Medicines
(AREA)
Abstract
"MéTODO PARA FERTILIZAçãO HUMANA IN VITRO, USO DE UM HORMÈNIO HIPOTALâMICO E/OU UM HORMÈNIO PITUITáRIO OU UM AGONISTA OU ANTAGONISTA DESTES OU UM DERIVADO ATIVO DESTES E, CONJUNTO FARMACêUTICO NA FORMA DE UNIDADE DE DOSAGEM PARA O USO NA FERTILIZAçãO IN VITRO". Em um método de fertilização in vitro, uma mulher é tratada com um hormónio hipotalârmico e/ou com um hormónio pituitário ou com um agonista ou antagonista destes ou com um derivado ativo destes por um curto período de tempo e, a seguir, usando-se o ovo ou os ovos de maturação de oócito in vitro são retirados da mulher e são maturados usando-se um composto que ativa a meiose."METHOD FOR IN VITRO HUMAN FERTILIZATION, USE OF A HYPOTHALAMIC HORMONE AND / OR A PITUITARY HORMONE OR AN AGONIST OR ANTAGONIST OF THESE OR AN ACTIVE DERIVATIVE OF THESE AND, PHARMACEUTICAL ASSEMBLY IN THE FORM OF UNIT OF USE OF THE UNIT OF THE UNIT OF USE. In an in vitro fertilization method, a woman is treated with a hypothalamic hormone and / or with a pituitary hormone or with an agonist or antagonist of these or with an active derivative of these for a short period of time and then using the egg or oocyte maturation eggs in vitro are removed from the woman and are matured using a compound that activates meiosis.
BR0008472-7A1999-02-242000-02-23
Method for human in vitro fertilization, use of a hypothalamic hormone and / or a pituitary hormone or an agonist or antagonist of these or an active derivative of these and a pharmaceutical unit in the form of a dosage unit for use in IVF
BR0008472A
(en)
Method for human in vitro fertilization, use of a hypothalamic hormone and / or a pituitary hormone or an agonist or antagonist of these or an active derivative of these and a pharmaceutical unit in the form of a dosage unit for use in IVF
PHARMACEUTICAL COMPOSITIONS INCLUDING AN OPIACEAN AND CALCIUM SALT ANTAGONIST AND ITS USE FOR THE TREATMENT OF PATHOLOGIES IN WHICH ENDORPHINS ARE INVOLVED.
NEW PHARMACEUTICALLY ACTIVE COMPOUNDS, THEIR USE IN THE MANUFACTURE OF MEDICINES, TREATMENT METHOD, PHARMACEUTICAL COMPOSITION, INTERMEDIATE COMPOUNDS AND PROCESS FOR THE MANUFACTURE OF SUCH COMPOUNDS
USE OF THE PARTIROID HORMONE CONSTITUTED BY A SEQUENCE OF AMINO ACIDS 1-34 OF THE HUMAN PARTIROID HORMONE TO REDUCE THE RISK OF VERTEBRAL AND NON-VERTEBRAL BONE FRACTURES.
SUBSTITUTED DERIVATIVES OF TETRAHIDROFURANO-3-ONAS, TETRAHIDROPIRANO-3- ONAS AND TETRAHIDROTIOFEN-3-ONAS, A PROCEDURE FOR THE PREPARATION OF A PHARMACEUTICAL COMPOSITION OF A MEDICINAL PRODUCT USEFUL AS INTERMEDIATE PROTEIN INHIBITORS
compound, methods of manufacturing the same, for treating or preventing a disease, for activating er function in a bone cell, for inhibiting er function in a cell, for inhibiting il-6 expression, for inhibiting growth of an er-expressing neoplastic cell, for prevention of spermatogenesis, for prevention of an adverse reproductive effect associated with exposure to a lack of natural or chemically environmental hormonal balance, and, composition
COMPOUNDS THAT ARE METABOLITES OF THE ACID (3 - {[(4-TERC-BUTILBENCIL) - (PIRIDIN-3-SULFONIL) AMINO] METHYL} PHENOXY) ACETIC, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM, AND DETERMINATION PROCEDURE
Legal Events
Date
Code
Title
Description
B08F
Application fees: dismissal - article 86 of industrial property law
Free format text:
REFERENTE A 4A, 5A, 6A, 7A E 8A ANUIDADES.
B08K
Lapse as no evidence of payment of the annual fee has been furnished to inpi (acc. art. 87)
Free format text:
REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 1925 DE 27/11/2007.